Loading…
WORK Medical Technology Group LTD
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in WOK.
▼ -100.0% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 2 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 |
|---|---|---|---|
| Year-end price | $218.00 | $4,820,000.00 | |
| P/S | — | 0.0x | 5.9x |
| P/B | — | 0.0x | 5.1x |
| EPS | -$10,414.24 | -$249,451.29 | |
| Profit margin | — | -10.89% | -30.35% |
| ROE | — | -5.85% | -26.49% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| NIKINiki BioSolutions, Inc. | $6.90 | — | 0.3x | — | -17.05% | $5.62M |
| KAPAKairos Pharma, LTD. | $0.24 | — | 1.2x | — | -113.96% | $5.62M |
| YCBDcbdMD, Inc. | $0.50 | 2.2x | 0.6x | — | -40.33% | $5.6M |
| LIMNLiminatus Pharma, Inc. | $4.23 |
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD has strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to develop data-model-application trinity for intelligent medical models. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Company description provided by Yahoo Finance.
| — |
| — |
| — |
| — |
| $5.68M |
| ZCMDZhongchao Inc. | $0.92 | — | 0.1x | — | -24.88% | $5.69M |
| NCNANuCana plc | $1.33 | 0.0x | 0.2x | — | -70.26% | $5.54M |